TBPHTheravance Biopharma, Inc.$16.91-0.03%
WAIT.
The entry isn't here — the timing triggers haven't fired.
2 of 5 usable entry checks are active; the rule needs 3. Move the price to stress-test the setup at another level.
QTick signal
-1net
0 bull / 1 bear factors · balancedBull 1 pts·Bear 2 pts30d
2 of 5 aligned — closing in
Waiting on the timing triggers to fire.
Market context—Sector read · not on file—Balance sheet · not on file—PCE sensitivity · not on fileOKNot a falling knife
Chart pattern
Death cross
50d below 200d · bearish structure
Volume vs 20-day avg0.03× · 16.5K vs 571.4K avg
52-week range$10.42 – $21.03
Below high since 2015-60.9% · $43.25 high
Risk / reward1 : 23.7
Plan stop$16.65
Max pain—
RSI 1453.3 fires under 35 · fires near $16.57
Forensic flags1 review
What-if price
$16.91
$16.47 · -2.6%-2.6%move the price to stress-test the setupdrag to test another price+0.6% · $17.00+0.6%
Entry strategy · 10 triggers2 of 5 aligned — closing in
RSI 14●
53.3
fires under 35 · fires near $16.57
vs 50-day✓
$16.76
at the line
Bollinger●
$16.80
no lower pierce · fires near $16.78
VWAP 20●
$16.89
above the rolling VWAP · fires near $16.89
Entry level✓
$16.83
within 1% of model level
Put wall●
—
not on file
MACD●
-0.07
below zero · still falling
RVolStatic
0.03×
below the 1.5× context threshold
Short int.Static
13.3%
short interest below 20%
ATRStatic
$0.05
14-session average true range
A checklist, not odds on a return: 3 of 5 usable price conditions have to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, relative volume and short interest are context only — they never count toward the total.
Next earnings
12 Aug 2026 · before the bell
bmo · in 0 days
Next dividend
No indicated yield
no forward dividend on file